Cipla shares ratings cut by Morgan Stanley, CLSA on earnings
- Elections 2014 LIVE: Narendra Modi slams Jayanti Natarajan; polling underway in 12 states
- Admiral Dhowan appointed as new Navy chief
- Is there a vikas vote? Healthier babies make not a whimper on campaign pitch in Hazaribagh
- Alagiri backs âgreat manâ Modi as PM
- CAG empowered to examine accounts of private telecom companies: Supreme Court
Morgan Stanley and CLSA downgraded their ratings on Cipla Ltd shares a day after the Indian drugmaker reported a slower-than-expected rise in its October-December net profit.
Morgan Stanley cut its ratings to "equal-weight" from "overweight", citing slower growth prospects on the back of limited niche drug launches, lower margins and a higher tax rate. The bank also cut its price target to 414 rupees from 437 rupees.
CLSA cut its ratings on Cipla to "underperform" from "outperform", citing disappointing margins in the October-December quarter and expectations near-term earnings growth will be slower due a higher base. The bank cut its price target to 415 rupees from 475 rupees.
- Activist, her aide booked for cheating in attempt to frame acquitted murder accused
- Extended Monorail running hours fails to pull crowd
- HC orders action against Essel World for causing harm to mangroves
- Cops crack bar girl’s murder case after waiter’s tip-off
- Railway to provide plastic pouches for commuter IDs
- Last safety check for Metro to begin April 18